
Top stories
See allAnalyzing tumor DNA in blood and urine may expand the options for monitoring the disease and help personalize treatment decisions.
Most Read
Study of the Week

Cholesterol medication after 70: what are the benefits and limits?
A trial of nearly 10,000 participants found a cardiovascular benefit with atorvastatin but did not show that it extended life free of dementia or persistent physical disability.

Test helps detect signs of bladder cancer that don’t show up on imaging scans

VO2 max: The number that became a “longevity score”

Cholesterol medication after 70: what are the benefits and limits?

Ovarian reserve and exercise
A promising hypothesis that science has not yet confirmed in women
Health & Science
The scientific discoveries that help us understand modern medicine.

Test helps detect signs of bladder cancer that don’t show up on imaging scans
Analyzing tumor DNA in blood and urine may expand the options for monitoring the disease and help personalize treatment decisions.
Mental Health & Behavior
The relationship between mind, emotions, behavior and quality of life.

Is eight hours of sleep enough?
Science is starting to show that sleep regularity may matter even more.
Nutrition & Metabolism
The science of nutrition, metabolism and eating habits.

GLP-1 drugs without a prescription: Brazilian study finds use in nearly 1 in 4 participants
A survey of 860 adults found that use without a prescription was more frequent among health professionals and participants without obesity, but the authors caution that the cross-sectional design does not allow them to conclude whether these people already fell outside clinical criteria when they started treatment.
Fitness & Performance
Movement, physical exercise, sports medicine and human performance.

VO2 max: The number that became a “longevity score”
Once limited to athletes and labs, the measure of maximal oxygen uptake has made its way onto smartwatches and become an indicator of health and longevity.
AI, Innovation & Health Business
The technologies, business models and transformations that are redefining health care.

Who is liable when a medical AI makes a mistake in Brazil?
A new rule from the CFM (Brazil’s Federal Council of Medicine) seeks to provide answers on the use of AI in health care, but international legal practice shows that assigning blame remains a gray area.

